79628 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Aging and 

Neurodegeneration Integrated Review Group; 

Clinical Neurodegeneration Translational 

Neuroscience Study Section. 

Date: October 24–25, 2024. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency, Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Meeting Format: In-Person Meeting. 

Contact Person: Jordan M. Moore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1002A1, 

Bethesda, MD 20892, (301) 451–0293, 

jordan.moore@nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics Study Section. 

Date: October 24–25, 2024. 

Time: 8:00 a.m. to 10:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Bethesdan Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Meeting Format: In-Person Meeting. 

Contact Person: Altaf Ahmad Dar, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 827–2680, altaf.dar@nih.gov 

Name of Committee: Social and 

Community Influences on Health Integrated 

Review Group; Social Sciences and 

Population Studies B Study Section. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Meeting Format: In-Person Meeting. 

Contact Person: Kate Fothergill, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive Room 3142, 

Bethesda, MD 20892, 301–435–2309, 

fothergillke@mail.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging 

Technology Development Study Section. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Brain Injury and Neurovascular 

Disorders Study Section. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Paula Elyse Schauwecker, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5201, 

Bethesda, MD 20892, 301–760–8207, 

schauweckerpe@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neuromodulation and Imaging of Neuronal 

Circuits. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Pablo Miguel Blazquez 

Gamez, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 435–1042, 

pablo.blazquezgamez@nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Pulmonary Vascular Disease and 

Physiology Study Section. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Bradley Nuss, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC7814 Bethesda, MD 20892, 301–451– 

8754, nussb@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Clinical Neuroplasticity and 

Neurotransmitters Study Section. 

Date: October 24–25, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Suzan Nadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1259, nadis@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

Molecular and Structural Immunology Study 

Section. 

Date: October 24–25, 2024. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Velasco Cimica, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, 301–594–1760, 

velasco.cimica@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Biophysical, Physiological, 

Pharmacological and Bioengineering 

Neuroscience, and Vision. 

Date: October 24–25, 2024. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Angela Monique Boutte, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Dr., Bethesda, MD 

20892, (301) 594–0063, boutteam@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 24, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22362 Filed 9–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Adolescent Brain & 

Cognitive Development (ABCD) 

StudySM—Audience Feedback Teams 

(National Institute on Drug Abuse) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 79629 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Kimberly 

LeBlanc, Scientific Program Manager, 

Division of Extramural Research, 

National Institute on Drug Abuse, C/O 

NIH Mail Center/Dock 11, 3WFN Room 

09C77 MSC 6021, Gaithersburg, MD 

20877 (20892 for USPS), or call non-tollfree number (301) 827–4102, or Email 

your request, including your address, to: 

kimberly.leblanc@nih.gov. Formal 

requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: This 

information collection was previously 

published in the Federal Register on 

October 2, 2023 (88 FR 67775–67776) 

and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. 

The National Institute on Drug Abuse 

(NIDA), National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Adolescent 

Brain & Cognitive Development (ABCD) 

StudySM —Audience Feedback Teams, 

0925–0781, exp., date 03/31/2027, 

REVISION National Institute on Drug 

Abuse (NIDA), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: The purpose of this 

information collection request is to 

solicit audience feedback to improve the 

data collection process for the 

Adolescent Brain Cognitive 

Development (ABCD) Study. Started in 

2015, the ABCD Study® follows a cohort 

of over 10,000 young people from preadolescence into adulthood to 

understand how growing brains are 

shaped by experiences and biology. To 

prepare for each year’s Study data 

collection, the National Institute of 

Health is collecting audience feedback 

on a selection of survey questions and 

research protocols. Parents/caregivers 

and teens who are the same age as the 

study cohort members but who are not 

Study participants review proposed 

questions and give feedback on 

questions’ clarity and acceptability. 

Recommendations from these findings 

help the ABCD Study team improve 

their protocol for a more-successful data 

collection. 

Audience feedback activities include 

a mix of asynchronous and scheduled, 

live data collection: web-based survey 

activities, virtual discussion boards, 

individual interviews, and discussions 

groups. Assembling a cohort of audience 

feedback participants who are familiar 

with the ABCD Study and participate in 

multiple data collection activities 

minimizes the burden required to 

familiarize new participants with the 

purpose of the Study and the 

expectations for audience feedback. 

The purpose of this revision is to 

update the stimuli for which teens and 

parents/caregivers are providing 

feedback on wording, clarity, and areas 

for improvement. This revision updates 

stimuli for which feedback is complete 

and includes options for new or revised 

stimuli and feedback questions. Burden 

levels remain unchanged. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

172. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

A—Parent/Caregiver Phone Screener and Invitation.Parents/Caregivers ....... 72 1 5/60 6 

B—Parent/Caregiver Consent .............................. Parents/Caregivers ....... 15 1 5/60 1 

C—Parent or Guardian Permission for Teens ..... Parents/Legal Guardians.36 1 5/60 3 

D—Teen Phone Screener .................................... Teens ............................ 72 1 5/60 6 

E—Teen Assent or F—Teen Consent ................. Teens ............................ 36 1 10/60 6 

G—Teen Web Survey .......................................... Teens ............................ 36 2 30/60 36 

H—Parent/Caregiver Web Survey ........................ Parents/Caregivers ....... 15 2 30/60 15 

I—Teen Virtual Discussion Group Guide or K— 

Teen Online Bulletin Board Guide.

Teens ............................ 36 2 1 72 

J—Parent/Caregiver Virtual Interview Guide ........ Parents/Caregivers ....... 15 1 30/60 8 

L—Parent/Caregiver Online Bulletin Board Guide Parents/Caregivers ....... 15 1 1 15 

M—Parent/Caregiver ‘‘At-Home’’ Materials Review.Parent/Caregivers ......... 15 1 15/60 4 

TOTAL ........................................................... ....................................... ........................ 450 ........................ 172 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2024–22367 Filed 9–27–24; 8:45 am] 

BILLING CODE 4140–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1